
Brian Huntly is a clinical research scientist who combines running a laboratory group at the University of Cambridge with his practice as a consultant haematologist and Chair of the Haematology Department at Cambridge University Hospitals. He is also Head of the Department of Haematology at the University of Cambridge, Co-Lead of the Cambridge Haematological Malignancies Virtual Institute and Interim Director of the Cancer Research UK Cambridge Centre. He is President Elect of the European Hematology Association, a member of its Executive Board and was formerly Chair of their Research Committee and Chair of the Scientific Programme Committee for the EHA Congress in 2024. His own research focuses on understanding how normal stem and progenitor cell function is subverted during the step-wise evolution of acute myeloid leukaemia and malignant lymphomas. Amongst other recognitions for his research, he has been elected to Fellowship of the Academy of Medical Sciences in the UK and won two consecutive Cancer Research UK Discovery Programme Awards. He has received funding for his research from the European Research Council and led EHA’s involvement in the EU-funded Innovative Medicines Initiative/Innovative Health Initiative HARMONY project for big data in haematological malignancies.
Updated: November 2025